Optimizing Disability Benefit Decisions and Outcomes in First Episode Psychosis
Optimizing Disability Benefit Decisions and Outcomes in First Episode Psychosis
批准号:
10521916
负责人:
LISA B. DIXON
金额:
$78.76万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-09 至 2028-06-30
关键词:
AffectAgeAttentionAwardBlack AmericanCOVID-19 pandemicCaliforniaCharacteristicsClientClinicalCommunitiesComplexConsolidated Framework for Implementation ResearchCoordinated Specialty CareDataData CollectionData SetDecision MakingDeteriorationDevelopmentDisincentiveEconomicsEmploymentEnrollmentEvaluationEvidence based practiceFeedbackFundingGenerationsGoalsImpairmentIndependent LivingIndividualInterruptionInterventionInterviewKnowledgeLearningLinkMedicaidMedicare/MedicaidMental Health ServicesMethodsMinorityModelingMotivationNational Institute of Mental HealthNew YorkOutcomePartnership PracticePennsylvaniaPersonsPlayPoliciesPopulationPovertyProcessPsychosesPsychotic DisordersRaceRecoveryResearchResearch PersonnelRoleSchizophreniaSchoolsService delivery modelServicesShockSiteSocial SecurityStructural RacismSurveysTexasTimeTranslational ResearchUnited StatesUnited States Social Security AdministrationWorkYouthagedcare recipientscare systemscareer developmentdesigndisabilitydisability impactearly psychosisevidence baseexperiencefirst episode psychosisimplementation strategyimprovedimproved outcomeinnovationminority childrenpreventprogramsracial differenceracial discriminationracial disparityracial identityresearch to practicesocialsocial determinantssocial influencesociodemographicsyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A major NIMH goal for early psychosis treatment is to “prevent deterioration and disability among
individuals suffering from psychotic illness”. However, rates of Social Security Administration disability (SSI/DI)
enrollment remain high for young people in early psychosis treatment. Existing studies on SSI/DI have limited
information on the FEP population. Enrollment in SSI/DI may provide benefits (including cash assistance,
access to Medicaid/Medicare, and other social entitlements), but also detrimentally impact identity, vocational
aspirations, career development and employment; individuals rarely leave SSAD benefits for full-time work.
Racial disparities have also been identified, but remain poorly understood, with respect to the intersections
between race, structural racism and the poorer outcomes long-documented among ethnoracialized minorities,
particularly Black Americans. It is crucial to generate knowledge with the potential to inform decision-making
about the benefits and trade-offs inherent in SSI/DI participation and help optimize outcomes within the context
of SSI/DI participation among this population of young people (e.g. generally aged 16-30).
The primary goal of this project is to investigate factors influencing decisions to apply for SSI/DI, the
impact of these decisions, and the longitudinal relationships between SSI/DI and career development. This
information will then be used to develop systematic strategies for improving services, supporting client decision
making and optimizing outcomes.
The NIMH-funded Early Psychosis Intervention Network (EPINET), spanning 105 coordinated specialty
care (CSC) programs across 16 states, affords an exceptional opportunity to better understand these issues.
Leveraging the EPINET initiative, this multi-phase, mixed methods study will provide important new knowledge
regarding predictors of application and the relationship between SSI/DI and vocational functioning, will facilitate
development and evaluation of a multi-level menu of actionable targets and associatedimplementation
strategies, for example, specific ways of improving programmatic supports and policy changes designed to
strengthen SSAD-related outcomes (translation of research to practice). The project is guided by the multi-level
Disability Creation Process (DCP2) framework, and implementation activities by the Consolidated Framework
for Implementation Research (CFIR). The proposed project will utilize quantitative data from the EPINET
common dataset (n=5000), supplemented with primary quantitative (n = 330) and qualitative (n = 110) data
collection in four distinct states. The study aims are to: determine the extent and predictors of SSI/DI
application, SSAD enrollment and work/school functioning among clients enrolled in CSC programs,
systematically investigate the client experience of SSI/DI decision making (through quantitative and qualitative
data) and using implementation mapping to develop strategies to optimize CSC services as they impact
SSI/DI. Racial differences and potential disparities will be examined across all three Aims.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Examining the effectiveness of a shared decision making intervention for antipsychotic medications to improve engagement in treatment for people experiencing early psychosis
-
批准号:10670896
-
项目类别:
-
资助金额:$23.47万
-
财政年份:2022
-
负责人:LISA B. DIXON
-
依托单位:
Examining the effectiveness of a shared decision making intervention for antipsychotic medications to improve engagement in treatment for people experiencing early psychosis
-
批准号:10510009
-
项目类别:
-
资助金额:$26.47万
-
财政年份:2022
-
负责人:LISA B. DIXON
-
依托单位:
Adapting Coordinated Specialty Care in the Post COVID-19 Era
-
批准号:10193474
-
项目类别:
-
资助金额:$32.43万
-
财政年份:2019
-
负责人:LISA B. DIXON
-
依托单位:
Zero Suicide Implementation and Evaluation in Outpatient Mental Health Clinics
-
批准号:10572128
-
项目类别:
-
资助金额:$52.15万
-
财政年份:2016
-
负责人:LISA B. DIXON
-
依托单位:
Improving Life Trajectories for Youth with Early Psychosis
-
批准号:8916281
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:LISA B. DIXON
-
依托单位:
OnTrack>An Online Role-Playing Game
-
批准号:9253043
-
项目类别:
-
资助金额:$67.69万
-
财政年份:2014
-
负责人:LISA B. DIXON
-
依托单位:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
-
批准号:8195952
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:LISA B. DIXON
-
依托单位:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
-
批准号:8392115
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:LISA B. DIXON
-
依托单位:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
-
批准号:7916627
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:LISA B. DIXON
-
依托单位:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
-
批准号:7786750
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:LISA B. DIXON
-
依托单位:
A Randomized Trial of Family to Family Education
-
批准号:7124695
-
项目类别:
-
资助金额:$58.16万
-
财政年份:2005
-
负责人:LISA B. DIXON
-
依托单位:
A Randomized Trial of Family to Family Education
-
批准号:7472451
-
项目类别:
-
资助金额:$45.75万
-
财政年份:2005
-
负责人:LISA B. DIXON
-
依托单位:
A Randomized Trial of Family to Family Education
-
批准号:6985018
-
项目类别:
-
资助金额:$53.23万
-
财政年份:2005
-
负责人:LISA B. DIXON
-
依托单位:
A Randomized Trial of Family to Family Education
-
批准号:7262413
-
项目类别:
-
资助金额:$58.11万
-
财政年份:2005
-
负责人:LISA B. DIXON
-
依托单位:
A Randomized Trial of Family to Family Education
-
批准号:7454711
-
项目类别:
-
资助金额:$5.88万
-
财政年份:2005
-
负责人:LISA B. DIXON
-
依托单位:
Do Practice Guidelines Reduce Smoking in Schizophrenia
-
批准号:6471404
-
项目类别:
-
资助金额:$51.04万
-
财政年份:2002
-
负责人:LISA B. DIXON
-
依托单位:
Do Practice Guidelines Reduce Smoking in Schizophrenia
-
批准号:6623942
-
项目类别:
-
资助金额:$59.87万
-
财政年份:2002
-
负责人:LISA B. DIXON
-
依托单位:
Do Practice Guidelines Reduce Smoking in Schizophrenia
-
批准号:6747738
-
项目类别:
-
资助金额:$40.72万
-
财政年份:2002
-
负责人:LISA B. DIXON
-
依托单位:
MORBIDITY IN SCHIZOPHRENIA--A FOCUS ON DIABETES
-
批准号:6186279
-
项目类别:
-
资助金额:$34.6万
-
财政年份:1999
-
负责人:LISA B. DIXON
-
依托单位:
MORBIDITY IN SCHIZOPHRENIA--A FOCUS ON DIABETES
-
批准号:6392380
-
项目类别:
-
资助金额:$38.86万
-
财政年份:1999
-
负责人:LISA B. DIXON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: